APL Swift Services (malta) Limited Pharmaceutical Import Profile — Malta (DGFT 2022–2026)

Name: APL Swift Services (malta) Limited Pharmaceutical Import Records from India — 36 Products, $173.8M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

APL Swift Services (malta) Limited — Pharmaceutical Importer Profile (2026) | 36 Products, $173.8M Trade | TransData Nexus

APL Swift Services (malta) Limited

Pharmaceutical Importer · Malta · Gastrointestinal Focus · $173.8M Total Trade · DGFT Verified

APL Swift Services (malta) Limited is a pharmaceutical importer based in Malta with a total trade value of $173.8M across 36 products in 17 therapeutic categories. Based on 6,189 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. APL Swift Services (malta) Limited sources from 10 verified Indian suppliers, with Aurobindo Pharma Limited accounting for 86.7% of imports.

APL Swift Services (malta) Limited — Import Portfolio & Supplier Network

APL Swift Services (malta) Limited import network — 36 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to APL Swift Services (malta) Limited?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Aurobindo Pharma Limited	$19.8M	2,348	86.7%
Fourrts (india) Laboratories Private Limited	$1.3M	53	5.5%
Aurobindo Pharma Ltd

What Formulations Does APL Swift Services (malta) Limited Import?

Formulation	Value	Ships
Pantoprazole tablets 40mgpantoprazol puren 40 MG magensaftresistente	$479.3K	11
Pantoprazole tablets 40mgpantoprazol puren 40 MG magensaftresistente	$271.8K	10
Naproxen 500MG tabletsnaproxen aurobindo 500 MG	$245.1K	8
Pantoprazole tablets 20mgpantoprazol puren 20 MG magensaftresistente	$242.5K	8
Levetiracetam tablets 500mglevetiracetam aurobindo 500 MG filmomhulde	$239.9K	5
Cefuroxime axetil tablets 500MG cefuroxim puren 500 MG	$220.8K	5
Naproxen 500MG tabletsapo-napro 500 MG	$213.2K	6
Levetiracetam tablets 500mglevetiracetam aurobindo 500 MG compresse	$190.8K	5
Cefuroxime axetil tablets 500MG cefuroxime axetil tablets BP 500MG	$161.6K	6
Ibuprofen tablets 600 mgibuprofeno aurovitas spain 600 MG comprimidosrecubiertos con	$160.4K	7
Ibuprofen tablets 600 mgibuprofen aurobindo 600 MG filmomhulde	$150.5K	5
Furosemide inovamed (furosemide 40MG tablets) (3x10 s)	$138.3K	3
Eplerenone tablets 25MG(eplerenon aurobindo 25 MG, filmomhulde tabletten	$133.7K	3
Pregabalin capsules 150 mgpregabalin aurobindo 150 MG	$130.8K	8
Pantoprazole tablets 40mgpantoprazol aurobindo 40 MG maagsapresistente	$128.0K	4

APL Swift Services (malta) Limited imports 1,908 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 30 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Pantoprazole	Gastrointestinal	$50.9M	1,018	3.8%	2
2	Atorvastatin	Cardiovascular	$25.9M	517	2.4%	7
3	Sertraline	CNS & Psychiatric	$11.8M	237	2.1%	3
4	Clopidogrel	Cardiovascular	$9.4M	307	1.9%	9
5	Gabapentin	CNS & Psychiatric	$7.8M	402	0.9%	16
6	Loratadine	Antihistamines & Allergy	$6.7M	167	3.9%	2
7	Simvastatin	Cardiovascular	$5.6M	295	4.5%	3
8	Cefuroxime	Advanced Antibiotics	$5.5M	271	2.0%	5
9	Amoxicillin	Antibiotics	$5.4M	189	0.9%	16
10	Naproxen	Analgesics & Antipyretics	$5.2M	291	3.9%	5
11	Metformin	Diabetes & Endocrine	$5.2M	103	1.1%	10
12	Ibuprofen	Analgesics & Antipyretics	$5.0M	260	0.9%	17
13	Potassium	Nutritional Supplements	$5.0M	144	0.8%	20
14	Enalapril	Cardiovascular	$3.5M	71	1.5%	2
15	Tramadol	Analgesics & Antipyretics	$2.7M	135	0.7%	8
16	Fluoxetine	CNS & Psychiatric	$2.1M	86	0.9%	12
17	Emtricitabine	Antiviral & HIV Medications	$1.9M	48	1.6%	9
18	Ertapenem	Advanced Antibiotics	$1.8M	36	1.1%	7
19	Terbinafine	Antifungals	$1.4M	143	2.8%	8
20	Furosemide	Diuretics	$1.3M	56	1.8%	11
21	Sitagliptin	Diabetes & Endocrine	$1.3M	61	1.7%	16
22	Ramipril	Cardiovascular	$1.2M	257	1.3%	15
23	Lisinopril	Cardiovascular	$1.0M	119	0.9%	9
24	Glimepiride	Diabetes & Endocrine	$780.5K	109	1.0%	6
25	Acetylsalicylic	Combination Drugs	$753.1K	41	14.3%	2
26	Carvedilol	Cardiovascular	$751.5K	149	0.8%	18
27	Loperamide	Gastrointestinal	$722.9K	193	1.0%	7
28	Propranolol	Cardiovascular	$680.6K	77	0.7%	11
29	Gemcitabine	Oncology	$631.4K	24	1.4%	16
30	Salicylic	Combination Drugs	$626.8K	35	3.7%	6

APL Swift Services (malta) Limited imports 36 pharmaceutical products across 17 categories into Malta totaling $173.8M.

APL Swift Services (malta) Limited — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

APL Swift Services (Malta) Limited is a pharmaceutical importer and buyer based in Malta, specializing in the procurement of finished pharmaceutical formulations from India. Established on December 12, 2007, the company operates under the ownership of Aurobindo Pharma Limited, a leading Indian pharmaceutical manufacturer. APL Swift Services (Malta) Limited plays a pivotal role in Malta's pharmaceutical distribution network, serving as a key conduit for the importation and distribution of a diverse range of pharmaceutical products.

The company's headquarters are situated at Vault 14, Level 2, Valletta Waterfront, Floriana, FRN 1913, Malta. APL Swift Services (Malta) Limited's strategic location and robust operational framework enable it to effectively manage the importation and distribution of pharmaceutical products, ensuring a steady supply to meet the healthcare needs of the Maltese population.

2Distribution Network

APL Swift Services (Malta) Limited operates a comprehensive distribution network designed to ensure the efficient delivery of pharmaceutical products across Malta. The company's facilities encompass a combined area of 7,000 square meters, featuring technologically advanced laboratories and resource-efficient operations. (whoswho.mt) These facilities are strategically located within the Ħal Far Industrial Estate, a hub for industrial and logistical operations in Malta.

The distribution network is characterized by its adherence to European Union Good Manufacturing Practice (EU GMP) standards, ensuring that all imported pharmaceutical products meet stringent quality and safety requirements. APL Swift Services (Malta) Limited's logistics capabilities are tailored to facilitate the swift and secure delivery of pharmaceutical products, catering to the needs of a diverse clientele across the Maltese islands.

3Industry Role

APL Swift Services (Malta) Limited holds a significant position within Malta's pharmaceutical supply chain, primarily functioning as a pharmaceutical importer and distributor. The company specializes in the importation of finished pharmaceutical formulations from India, encompassing a wide array of therapeutic categories. By sourcing products from reputable Indian manufacturers, APL Swift Services (Malta) Limited contributes to the diversification and availability of pharmaceutical products in the Maltese market.

The company's role extends beyond mere importation; it serves as a critical link between Indian pharmaceutical manufacturers and the Maltese healthcare system. Through its efficient distribution network and adherence to EU GMP standards, APL Swift Services (Malta) Limited ensures that imported pharmaceutical products are accessible to healthcare providers and patients across Malta, thereby supporting the overall health infrastructure of the country.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — APL Swift Services (malta) Limited

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

APL Swift Services (Malta) Limited demonstrates a high degree of sourcing concentration, with a substantial portion of its pharmaceutical imports originating from a single supplier, Aurobindo Pharma Limited. This supplier accounts for approximately 86.7% of the total import value, amounting to $19.8 million across 2,348 shipments. (whoswho.mt)

The concentration of imports from Aurobindo Pharma Limited suggests a strategic partnership, likely aimed at ensuring a consistent and reliable supply of pharmaceutical products. This relationship may offer benefits such as favorable pricing, priority access to new products, and streamlined logistics. However, the high dependency on a single supplier also introduces potential risks, including supply chain disruptions in the event of issues at the supplier's end.

To mitigate these risks, APL Swift Services (Malta) Limited has diversified its supplier base, engaging with other Indian pharmaceutical manufacturers. For instance, Fourrts (India) Laboratories Private Limited supplies products worth $1.3 million across 53 shipments, representing 5.5% of the total import value. (whoswho.mt) This diversification strategy enhances supply chain resilience and reduces the impact of potential disruptions from any single supplier.

2Supply Chain Resilience

APL Swift Services (Malta) Limited's supply chain resilience is bolstered by its diversified supplier base and adherence to stringent quality standards. The company's primary supplier, Aurobindo Pharma Limited, is a well-established Indian pharmaceutical manufacturer known for its extensive product portfolio and compliance with international quality standards. This partnership ensures a steady supply of pharmaceutical products that meet the regulatory requirements of the European Union.

Importing Pharmaceuticals into Malta — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Malta

1Regulatory Authority & Framework

In Malta, the Medicines Authority serves as the primary regulatory body overseeing the pharmaceutical sector. This authority is responsible for ensuring that all medicinal products, including those imported into Malta, comply with the principles and guidelines of Good Manufacturing Practice (GMP). (medicinesauthority.gov.mt) The Medicines Authority enforces regulations that govern the manufacture, importation, and distribution of pharmaceutical products, ensuring they meet the required quality standards for human use.

Key legislation governing pharmaceutical imports in Malta includes the Medicines Act, 2003, and relevant EU Directives. These regulations outline the requirements for marketing authorization, GMP compliance, and the overall safety and efficacy of medicinal products. The Medicines Authority's role encompasses the evaluation and monitoring of pharmaceutical products to safeguard public health and maintain the integrity of the pharmaceutical supply chain.

2Import Licensing & GMP

Import licensing requirements in Malta stipulate that all pharmaceutical products imported into the country must be authorized by the Medicines Authority. This authorization process ensures that imported products meet the necessary quality standards and are safe for public use. Additionally, the Medicines Authority requires that all medicinal products for human use, whether manufactured domestically or imported, adhere to Good Manufacturing Practice (GMP) guidelines. (medicinesauthority.gov.mt)

APL Swift Services (malta) Limited — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

APL Swift Services (Malta) Limited's product category focus is strategically aligned with the therapeutic needs of the Maltese population. The company's top five imported products include Pantoprazole, Atorvastatin, Sertraline, Clopidogrel, and Gabapentin, which collectively account for 60.9% of the total import value. (whoswho.mt)

The emphasis on these specific therapeutic areas—gastrointestinal, cardiovascular, and central nervous system (CNS) & psychiatric—reflects a targeted approach to address prevalent health conditions in Malta.

TransData Nexus Research · DGFT trade data analysisMar 2026

Frequently Asked Questions — APL Swift Services (malta) Limited

What products does APL Swift Services (malta) Limited import from India?

APL Swift Services (malta) Limited imports 36 pharmaceutical products across 17 categories. Top imports: Pantoprazole ($50.9M), Atorvastatin ($25.9M), Sertraline ($11.8M), Clopidogrel ($9.4M), Gabapentin ($7.8M).

Who supplies pharmaceuticals to APL Swift Services (malta) Limited from India?

APL Swift Services (malta) Limited sources from 10 verified Indian suppliers. The primary supplier is Aurobindo Pharma Limited (86.7% of imports, $19.8M).

What is APL Swift Services (malta) Limited's total pharmaceutical import value?

APL Swift Services (malta) Limited's total pharmaceutical import value from India is $173.8M, based on 6,189 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does APL Swift Services (malta) Limited focus on?

APL Swift Services (malta) Limited imports across 17 categories. The largest: Gastrointestinal (29.7%), Cardiovascular (28.0%), CNS & Psychiatric (12.7%).

Get Full APL Swift Services (malta) Limited Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 6 company name variants from customs records. For current shipment-level data, contact TransData Nexus.

APL Swift Services (malta) Limited

APL Swift Services (malta) Limited — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to APL Swift Services (malta) Limited?

What Formulations Does APL Swift Services (malta) Limited Import?

What Products Does APL Swift Services (malta) Limited Import?

Top Products by Import Value

APL Swift Services (malta) Limited Therapeutic Categories — 17 Specializations